Foamix Pharmaceuticals Shares Outstanding 2014-2018 | FOMX

Foamix Pharmaceuticals shares outstanding from 2014 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Foamix Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2017 37
2016 32
2015 28
2014 15
2013 11
Foamix Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 41
Q2 2018 40
Q1 2018 38
Q4 2017 37
Q3 2017 37
Q2 2017 37
Q1 2017 37
Q4 2016 32
Q3 2016 31
Q2 2016 31
Q1 2016 31
Q4 2015 28
Q3 2015 31
Q2 2015 26
Q1 2015 23
Q4 2014 20
Q3 2014 13
Q2 2014 11
Q1 2014 11
Q4 2013 0
Q3 2013 11
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.222B $0.004B
Foamix Pharmaceuticals Ltd. is a specialty pharmaceutical company. It develops and commercializes foam-based formulations acne, impetigo, and other skin conditions. The Company's lead product candidates include FMX101, which has completed a dose-ranging Phase II clinical trial for the treatment of moderate-to-severe acne; and FMX102 that has completed a Phase II clinical trial for the treatment of impetigo. It has operations primarily in the United States, Germany, and Israel. Foamix Pharmaceuticals Ltd. is headquartered in Rehovot, Israel.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $52.737B 11.25
Zoetis (ZTS) United States $42.323B 28.98
Grifols (GRFS) Spain $13.151B 16.05
Tilray (TLRY) United States $9.340B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.516B 12.22
Neurocrine Biosciences (NBIX) United States $7.634B 1683.60
Ionis Pharmaceuticals (IONS) United States $7.308B 0.00
Nektar Therapeutics (NKTR) United States $6.402B 9.18
Catalent (CTLT) United States $5.280B 22.15
Impax Laboratories (AMRX) United States $5.180B 0.00
Sage Therapeutics (SAGE) United States $4.814B 0.00
United Therapeutics (UTHR) United States $4.770B 7.80
Loxo Oncology (LOXO) United States $4.133B 0.00
TESARO (TSRO) United States $4.071B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.986B 14.76
FibroGen (FGEN) United States $3.227B 0.00
USANA Health Sciences (USNA) United States $2.879B 24.51
Endo (ENDP) Ireland $2.596B 3.98
Xencor (XNCR) United States $2.114B 0.00
Heron Therapeutics (HRTX) United States $2.071B 0.00
Endocyte (ECYT) United States $1.956B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.901B 256.83
Ironwood Pharmaceuticals (IRWD) United States $1.896B 0.00
Aerie Pharmaceuticals (AERI) United States $1.804B 0.00
Zogenix (ZGNX) United States $1.786B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.740B 0.00
PTC Therapeutics (PTCT) United States $1.683B 0.00
Corcept Therapeutics (CORT) United States $1.506B 22.10
Theravance Biopharma (TBPH) Cayman Islands $1.484B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.419B 19.95
Esperion Therapeutics (ESPR) United States $1.381B 0.00
Portola Pharmaceuticals (PTLA) United States $1.374B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.321B 0.00
Tricida (TCDA) United States $1.258B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.156B 0.00
TherapeuticsMD (TXMD) United States $1.078B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.963B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.800B 0.00
ImmunoGen (IMGN) United States $0.796B 0.00
Radius Health (RDUS) United States $0.721B 0.00
Collegium Pharmaceutical (COLL) United States $0.634B 0.00
Karyopharm Therapeutics (KPTI) United States $0.608B 0.00
Forty Seven (FTSV) United States $0.572B 0.00
Flexion Therapeutics (FLXN) United States $0.566B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.522B 0.00
ChemoCentryx (CCXI) United States $0.498B 39.40
Akebia Therapeutics (AKBA) United States $0.487B 0.00
Siga Technologies (SIGA) United States $0.476B 0.00
Dermira (DERM) United States $0.459B 0.00
GlycoMimetics (GLYC) United States $0.455B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.452B 0.00
Xeris Pharmaceuticals (XERS) United States $0.429B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.421B 24.85
Dova Pharmaceuticals (DOVA) United States $0.408B 0.00
Odonate Therapeutics (ODT) United States $0.402B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.395B 0.00
ArQule (ARQL) United States $0.390B 0.00
Tyme Technologies (TYME) United States $0.389B 0.00
Translate Bio (TBIO) United States $0.385B 0.00
KalVista Pharmaceuticals (KALV) United States $0.385B 0.00
CASI Pharmaceuticals (CASI) United States $0.372B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.362B 0.00
Aclaris Therapeutics (ACRS) United States $0.338B 0.00
OptiNose (OPTN) United States $0.333B 0.00
Tapimmune (MRKR) United States $0.326B 0.00
Aratana Therapeutics (PETX) United States $0.312B 0.00
Minerva Neurosciences (NERV) United States $0.309B 0.00
Concert Pharmaceuticals (CNCE) United States $0.293B 0.00
Majesco Entertainment (PTE) United States $0.293B 0.00
Depomed (ASRT) United States $0.273B 10.17
Mast Therapeutics (SVRA) United States $0.268B 0.00
IMV INC (IMV) Canada $0.266B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.263B 0.00
Affimed (AFMD) Germany $0.250B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.246B 0.00
Aldeyra Therapeutics (ALDX) United States $0.242B 0.00
Ocular Therapeutix (OCUL) United States $0.239B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.210B 0.00
Lannett Co Inc (LCI) United States $0.209B 1.82
AcelRx Pharmaceuticals (ACRX) United States $0.208B 0.00
Aquestive Therapeutics (AQST) United States $0.206B 0.00
Galectin Therapeutics (GALT) United States $0.204B 0.00
TAIWAN LIPOSOME (TLC) Taiwan $0.198B 0.00
Opexa Therapeutics (ACER) United States $0.195B 0.00
Zafgen (ZFGN) United States $0.189B 0.00
Calithera Biosciences (CALA) United States $0.187B 0.00
MEI Pharma (MEIP) United States $0.184B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.175B 0.00
ContraFect (CFRX) United States $0.171B 0.00
Nature's Sunshine Products (NATR) United States $0.170B 0.00
Recro Pharma (REPH) United States $0.170B 0.00
Neon Therapeutics (NTGN) United States $0.162B 0.00
Molecular Templates (MTEM) United States $0.160B 0.00
ElectroCore (ECOR) United States $0.151B 0.00
Redhill Biopharma (RDHL) Israel $0.150B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.149B 0.00
MediWound (MDWD) Israel $0.146B 0.00
Ardelyx (ARDX) United States $0.145B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.135B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.134B 0.00
Jounce Therapeutics (JNCE) United States $0.129B 0.00
DURECT (DRRX) United States $0.127B 0.00
Cardiome Pharma (CORV) Canada $0.125B 0.00
Adherex Technologies (FENC) United States $0.122B 0.00
ProNAi Therapeutics (SRRA) Canada $0.113B 0.00
Champions Oncology (CSBR) United States $0.113B 0.00
Iterum Therapeutics (ITRM) Ireland $0.110B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.099B 0.00
Immune Design (IMDZ) United States $0.097B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.096B 0.00
Melinta Therapeutics (MLNT) United States $0.094B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.089B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.088B 0.00
CTI BioPharma (CTIC) United States $0.088B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.078B 0.00
Natural Alternatives (NAII) United States $0.077B 7.60
KemPharm (KMPH) United States $0.075B 0.00
Infinity Pharmaceuticals (INFI) United States $0.073B 0.00
Otonomy (OTIC) United States $0.072B 0.00
BioLineRx (BLRX) Israel $0.070B 0.00
Nivalis Therapeutics (ALPN) United States $0.066B 0.00
Achaogen (AKAO) United States $0.064B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.061B 0.00
Neos Therapeutics (NEOS) United States $0.059B 0.00
Avenue Therapeutics (ATXI) United States $0.053B 0.00
Forward Pharma (FWP) Denmark $0.052B 0.00
Genocea Biosciences (GNCA) United States $0.050B 0.00
Mannatechorporated (MTEX) United States $0.047B 0.00
Capnia (SLNO) United States $0.038B 0.00
Novan (NOVN) United States $0.036B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.036B 0.00
ProPhase Labs (PRPH) United States $0.036B 0.00
Heat Biologics (HTBX) United States $0.031B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.031B 0.00
Lipocine (LPCN) United States $0.030B 0.00
Trillium Therapeutics (TRIL) Canada $0.030B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.028B 0.00
PharmAthene (ALT) United States $0.028B 0.00
Xenetic Biosciences (XBIO) United States $0.024B 0.00
Biomerica (BMRA) United States $0.024B 0.00
Jaguar Animal Health (JAGX) United States $0.023B 0.00
HANCOCK JAFFE (HJLI) United States $0.022B 0.00
Aviragen Therapeutics (VXRT) United States $0.021B 0.00
Cyanotech (CYAN) United States $0.021B 0.00
Onconova Therapeutics (ONTX) United States $0.021B 0.00
Citius Pharmaceuticals (CTXR) United States $0.019B 0.00
Pain Therapeutics (PTIE) United States $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.017B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.017B 6.10
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.017B 0.00
ESSA Pharma (EPIX) Canada $0.016B 0.00
Shineco (TYHT) China $0.015B 1.65
Regulus Therapeutics (RGLS) United States $0.013B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.012B 0.00
Skyline Medical (AIPT) United States $0.011B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.010B 0.00
Aradigm (ARDM) United States $0.008B 0.00
Apricus Biosciences (APRI) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.008B 0.00
Midatech Pharma (MTP) United Kingdom $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.005B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.004B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.003B 0.00
Intellipharmaceutics (IPCI) Canada $0.003B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00